BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 12509641)

  • 1. Life-threatening reversible bone marrow toxicity in a rheumatoid arthritis patient switched from leflunomide to infliximab.
    Marchesoni A; Arreghini M; Panni B; Battafarano N; Uziel L
    Rheumatology (Oxford); 2003 Jan; 42(1):193-4. PubMed ID: 12509641
    [No Abstract]   [Full Text] [Related]  

  • 2. Pancytopenia associated with leflunomide and methotrexate.
    Hill RL; Topliss DJ; Purcell PM
    Ann Pharmacother; 2003 Jan; 37(1):149. PubMed ID: 12503951
    [No Abstract]   [Full Text] [Related]  

  • 3. Leflunomide-associated pancytopenia with or without methotrexate.
    Chan J; Sanders DC; Du L; Pillans PI
    Ann Pharmacother; 2004; 38(7-8):1206-11. PubMed ID: 15187208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leflunomide in combination therapy for rheumatoid arthritis.
    Savage RL
    Drug Saf; 2010 Jun; 33(6):523-6. PubMed ID: 20486733
    [No Abstract]   [Full Text] [Related]  

  • 5. Severe pancytopenia after leflunomide in rheumatoid arthritis.
    Auer J; Hinterreiter M; Allinger S; Kirchgatterer A; Knoflach P
    Acta Med Austriaca; 2000; 27(4):131-2. PubMed ID: 10989684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of antinuclear antibodies in patients with rheumatoid arthritis treated with infliximab and leflunomide.
    Bingham SJ; Buch MH; Kerr MA; Emery P; Valadäo Barcelos AT
    Arthritis Rheum; 2004 Dec; 50(12):4072-3. PubMed ID: 15593202
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative effectiveness of tumour necrosis factor alpha inhibitors in combination with either methotrexate or leflunomide.
    Strangfeld A; Hierse F; Kekow J; von Hinueber U; Tony HP; Dockhorn R; Listing J; Zink A
    Ann Rheum Dis; 2009 Dec; 68(12):1856-62. PubMed ID: 19126559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of leflunomide plus infliximab combination therapy in rheumatoid arthritis.
    Godinho F; Godfrin B; El Mahou S; Navaux F; Zabraniecki L; Cantagrel A
    Clin Exp Rheumatol; 2004; 22(3):328-30. PubMed ID: 15144127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of leflunomide and infliximab versus methotrexate and infliximab combination therapy in rheumatoid arthritis.
    Cobo Ibáñez T; Yehia Tayel M; Balsa Criado A; Hernández Sanz A; Martín Mola E
    Rheumatology (Oxford); 2005 Nov; 44(11):1467-8. PubMed ID: 16174647
    [No Abstract]   [Full Text] [Related]  

  • 10. Methotrexate versus leflunomide in rheumatoid arthritis: what is new in 2011?
    Singer O; Gibofsky A
    Curr Opin Rheumatol; 2011 May; 23(3):288-92. PubMed ID: 21378570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infliximab and leflunomide combination therapy in rheumatoid arthritis: an open-label study.
    Kiely PD; Johnson DM
    Rheumatology (Oxford); 2002 Jun; 41(6):631-7. PubMed ID: 12048288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate and leflunomide combination therapy for patients with active rheumatoid arthritis.
    Mroczkowski PJ; Weinblatt ME; Kremer JM
    Clin Exp Rheumatol; 1999; 17(6 Suppl 18):S66-8. PubMed ID: 10589360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination treatment with infliximab and leflunomide in patients with active rheumatoid arthritis: safety and efficacy in an open-label clinical trial.
    Kalden JR; Nüsslein HG; Wollenhaupt J; Burmester GR; Krüger K; Antoni C
    Clin Exp Rheumatol; 2008; 26(5):834-40. PubMed ID: 19032816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancytopenia, including macrocytic anemia, associated with leflunomide in a rheumatoid arthritis patient.
    Toyokawa Y; Kingetsu I; Yasuda C; Yasuda J; Yoshida K; Kurosaka D; Yamada A
    Mod Rheumatol; 2007; 17(5):436-40. PubMed ID: 17929140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of previous and concomitant leflunomide on the efficacy and safety of infliximab therapy in patients with rheumatoid arthritis; a longitudinal observational study.
    Flendrie M; Creemers MC; Welsing PM; van Riel PL
    Rheumatology (Oxford); 2005 Apr; 44(4):472-8. PubMed ID: 15598707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etanercept, infliximab, and leflunomide in established rheumatoid arthritis: clinical experience using a structured follow up programme in southern Sweden.
    Geborek P; Crnkic M; Petersson IF; Saxne T;
    Ann Rheum Dis; 2002 Sep; 61(9):793-8. PubMed ID: 12176803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leflunomide-induced polymyositis in a patient with rheumatoid arthritis.
    Ochi S; Taniguchi K; Nagashima M
    Mod Rheumatol; 2009; 19(4):443-6. PubMed ID: 19526307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug therapy and malpractice exemplified by combination leflunomide and methotrexate therapy].
    Burgardt C
    Z Rheumatol; 2002 Apr; 61(2):189-90. PubMed ID: 12056298
    [No Abstract]   [Full Text] [Related]  

  • 19. "Stepping-up" from methotrexate: a systematic review of randomised placebo controlled trials in patients with rheumatoid arthritis with an incomplete response to methotrexate.
    Hochberg MC; Tracy JK; Flores RH
    Ann Rheum Dis; 2001 Nov; 60 Suppl 3(Suppl 3):iii51-4. PubMed ID: 11890654
    [No Abstract]   [Full Text] [Related]  

  • 20. [Leflunomide + methotrexate combination therapy from the physician's viewpoint].
    Reinhold-Keller E; Gromnica-Ihle E
    Z Rheumatol; 2002 Apr; 61(2):191-3. PubMed ID: 12056299
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.